Ocata Therapeutics (OCAT) Reports Q3 Loss Per Share of $0.09
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall Street closes lower as oil prices jump, indexes notch monthly gains
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
- Energy stocks rally as fresh U.S.-Iran attacks drive oil prices higher
- BofA turns S&P 500 signals from red to yellow: What to buy now
Ocata Therapeutics to Host Conference Call and Webcast to Provide Corporate Update for the Third Quarter of 2015
November 6, 2015 3:30 PM ESTCall Scheduled for Monday, November 9, 2015 at 8:30 A.M.
MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Ocata Therapeutics, Inc. (NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology announced today that it will host a conference call on Monday, November 9th, 2015 at 8:30 a.m. EST, during which it will provide a corporate update for the third quarter of 2015.
Interested parties may access the call live by dialing (888) 539-3679 (US) or (719) 325-2370 (international) and using conference ID 1107447.
A live audio webcast of the presentation will be available via the... More
